Nathaniel Simons
Meritage Group
Nathaniel Simons Quest Diagnostics Incorporated stake
total: 301
Meritage Group DGX trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2016 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2017 Q1
According to 2026 Q2 report, Nathaniel Simons doesn't hold any Quest Diagnostics Incorporated (DGX) shares. To date, the estimated cost basis is nearly $91.91 for "buy" trades and estimated average "sell" price is $91.91. Meritage Group first purchased DGX in 2016 Q4, initially acquiring 18,747 shares. Since the initial investment in Quest Diagnostics Incorporated (DGX), Meritage Group has made 1 more transaction.
When did Nathaniel Simons sell Quest Diagnostics Incorporated (DGX)?
Nathaniel Simons sold off the entire Quest Diagnostics Incorporated (DGX) position in 2017 Q1.
When did Nathaniel Simons buy Quest Diagnostics Incorporated (DGX)?
Nathaniel Simons first invested in Quest Diagnostics Incorporated (DGX) in 2016 Q4 at the reported quarter-end price of $91.91 per share.
What's the cost basis of Meritage Group's DGX stake?
The estimated cost basis for Quest Diagnostics Incorporated (DGX) stake is around $91.91 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $91.91
- Weighted AVG sell price:
- $91.91
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.